aTyr Pharma Announces Appointment of Timothy P. Coughlin to its Board of Directors
10 avr. 2017 17h00 HE
|
aTyr Pharma Inc.
SAN DIEGO, April 10, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe,...